Advertisement

TheBodyPRO.com Covers CROI 2017

News

What to Expect for CROI 2017

February 10, 2017

The annual Conference on Retroviruses and Opportunistic Infections (CROI) kicks off next week in Seattle. This year's program covers a range of topics of interest to advocates including new data on basic science, a look at clinical trial design, planning to end the epidemic in New York, applying good participatory practices in research, understanding HIV and substance use and more.

Whether you're en route to Seattle for the four-day meeting or following the proceedings from your favorite wifi-enabled device, this update is for you. Read on to learn more!

A few events are at the top of our list.

Advertisement
On Sunday, AIDS Treatment Activists Coalition, AVAC, DefeatHIV,European AIDS Treatment Group, Project Inform and Treatment Action Group are sponsoring a day-long community cure workshop. The workshop brings together educators and advocates interested in learning about HIV cure research. Attendees spend half of the day hearing from leading researchers about developments in the HIV cure field followed by a strategy session dedicated to developing and increasing advocacy around those topics. The community event is open to all but is nearing capacity. Please be in touch if you are interested in attending.

Monday's agenda includes the Martin Delaney Presentation (12:15pm in Room 6AB), held in honor of the late HIV activist Martin Delaney. This year's lecture will focus on Good Participatory Practice Guidelines (GPP) and include presentations from AVAC staff and partners. Through a series of discussions, presentations and feedback from participants, this panel will provide global highlights of GPP and build awareness around their significance in the research process. Please be sure to add it to your Seattle agenda!

And please join fellow advocates and activists on Wednesday night for a community reception, 6-9pm at Tap House. Download the flyer for more information.


Real-Time Coverage

CROI also offers excellent webcast coverage, including live reports of the press conferences (press conference schedule available here), as well as taped playbacks. Electronic posters will be available a week after the conference and webcasts of the sessions will be archived online. Visit their electronics materials page for more.

As in years past, Medscape and aidsmap will be covering the conference with their excellent in-depth reporting across a range of research areas, including HIV prevention. And you can follow all the latest on Twitter at #CROI2017 where AVAC and others will be tweeting the latest data in 140 characters or less.

As always, please be in touch with any questions, and we look forward to seeing some of you in Seattle -- and working with all of you post-CROI to plot what's next!


Related Stories

CROI 2017 Preview: New Research on HIV Cure and Treatment
Don't Get Left Behind: New Scientific Findings to Be Presented at CROI 2017



This article was provided by AVAC: Global Advocacy for HIV Prevention. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections. Visit AVAC's website to find out more about their activities and publications.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.